IMPROVED PROCESS FOR PREPARATION OF IMATINIB AND ITS MESYLATE SALT

摘要

Disclosed is a process for the preparation of imatinib of formula (I), or its mesylate salt with controlled level of genotoxic impurity of formula (II), a key intermediate for imatinib.